FDA authorizes Merck pill for COVID-19 treatment
WASHINGTON — The Food and Drug Administration on Thursday authorized Merck’s COVID-19 pill for certain adults. The authorization for molnupiravir is limited to adults over 18 who have a high risk of severe illness and “for whom alternative FDA-authorized treatment options are not accessible or medically appropriate,” the FDA said in a press release Thursday.